PCSK9 linked to new-onset diabetes after kidney transplantation
from HealthDay News via Renal & Urology News
For renal transplant recipients (RTRs) without diabetes, circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) is associated with new-onset diabetes after transplantation (NODAT), according to a study published online in Diabetes Care. Michele F. Eisenga, MD, from the University of Groningen in the Netherlands, and colleagues examined the correlation between serum PCSK9 levels and NODAT development among RTRs without diabetes with a functional graft for at least 1 year.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063